Despite being insulin secreting competent, this missing potential in the regenerated β-like cells hampered the overall perspective of using UCB-MSPCs in cell therapy trials for diabetes and requires further investigation and optimization to realize the impact of UCB-MSPCs in generation of fully functional insulin-producing cells. Here, INS is linked to diabetes mellitus.